| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $223,018,856 ) (Continued on the next page) |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 001 | 2 | NIH | 6/13/2025 | $39,101 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 000 | 2 | NIH | 2/25/2025 | $351,923 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 002 | 11 | NIH | 4/9/2025 | $46,751 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 002 | 11 | NIH | 4/9/2025 | $226,156 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $420,761 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $2,035,408 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA267990 | Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine | 000 | 4 | NIH | 1/28/2025 | $324,186 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM083925 | Finite Elements For Biomechanics And Biophysics | 002 | 18 | NIH | 7/14/2025 | $475,402 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA267990 | Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine | 001 | 4 | NIH | 5/28/2025 | $36,020 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA264971 | Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s | 000 | 4 | NIH | 1/28/2025 | $503,493 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA263505 | SOX2 acts in the 3D genome of squamous cancer | 001 | 2 | NIH | 6/2/2025 | $40,800 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA263505 | SOX2 acts in the 3D genome of squamous cancer | 000 | 2 | NIH | 12/19/2024 | $367,201 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AG084477 | Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk | 001 | 3 | NIH | 8/12/2025 | $775,593 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21HL172288 | Overcoming explainability and data availability barriers to broad application of ECG ML screening with a system-wide ECG dataset | 000 | 2 | NIH | 12/13/2024 | $115,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167866 | Pathobiological mechanisms of cardiac disease in PGM1-CDG | 000 | 2 | NIH | 11/14/2024 | $586,682 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL164715 | Endometriosis Diagnosis and Subtypes, Reproductive History, and Cardiovascular Disease | 001 | 3 | NIH | 7/25/2025 | $675,463 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R61MH135109 | Capturing Autobiographical memory formation in People moving Through real-world spaces Using synchronized wearables and intracranial Recordings of EEG | 001 | 2 | NIH | 5/22/2025 | -$99,713 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R61MH135109 | Capturing Autobiographical memory formation in People moving Through real-world spaces Using synchronized wearables and intracranial Recordings of EEG | 000 | 2 | NIH | 5/17/2025 | $997,132 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS137233 | PASK-regulated genes and proteins as therapeutic targets for ALS and FTD | 001 | 2 | NIH | 7/28/2025 | $764,464 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T2653692 | Opioid-Impacted Family Support Program | 00 | 2 | HRSA | 8/13/2025 | $592,034 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 001 | 8 | NIH | 6/3/2025 | $38,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 8 | NIH | 3/7/2025 | $346,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 001 | 4 | NIH | 4/24/2025 | $89,298 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 000 | 4 | NIH | 2/27/2025 | $803,674 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI194555 | TCR-dependent and epigenetic mechanisms guiding influenza-specific CD4+ T cell responses in the lung | 000 | 1 | NIH | 7/23/2025 | $3,078,308 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R03AI178099 | RNA Sequencing if Esophageal Tissues During Food Elimination and Reintroduction Reveals Novel Findings Regarding the Early Pathogenesis of EoE | 000 | 1 | NIH | 8/12/2025 | $153,799 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR083990 | Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering | 001 | 2 | NIH | 5/7/2025 | $29,303 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR083990 | Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering | 000 | 2 | NIH | 3/20/2025 | $376,768 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA306216 | Defining the Regulatory Function of SOX2 in Squamous Cell Carcinoma | 001 | 1 | NIH | 8/1/2025 | $0 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA306216 | Defining the Regulatory Function of SOX2 in Squamous Cell Carcinoma | 000 | 1 | NIH | 8/1/2025 | $40,223 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NR020784 | A Novel mHealth Intervention to Improve Outcomes of Children with Medical Complexity | 001 | 2 | NIH | 6/6/2025 | $605,474 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG083580 | Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer | 001 | 2 | NIH | 6/10/2025 | $61,985 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG083580 | Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer | 000 | 2 | NIH | 3/20/2025 | $697,349 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R13HD079163 | PRS Young Investigators Grants Workshop | 001 | 12 | NIH | 4/8/2025 | $10,000 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM160566 | Mechanisms of compartmentalized signaling in electrically excitable cells | 000 | 1 | NIH | 8/1/2025 | $423,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS140319 | Overcoming Therapy Resistance in Hedgehog Pathway-Driven Medulloblastoma | 000 | 1 | NIH | 7/31/2025 | $611,591 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R03NS145583 | Sustainable Software Tools for Neuromodulation Prediction | 000 | 1 | NIH | 8/5/2025 | $244,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS144236 | Neuronal RNA binding proteins regulate brain formation | 000 | 1 | NIH | 7/31/2025 | $512,423 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA294770 | Elucidating the functional role and therapeutic potential of GPCR kinase 2 in primary and therapy-resistant basal cell carcinoma | 000 | 1 | NIH | 8/5/2025 | $669,949 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM160200 | Xenobiotic induction mechanisms affecting pharmacokinetics and pharmacodynamics among medically complex children, adolescents, and young adults. | 000 | 1 | NIH | 8/11/2025 | $2,117,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI182215 | Epigenetic programing of CD4+ T cell proliferation, survival and function during chronic viral infection | 000 | 1 | NIH | 7/31/2025 | $743,752 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD119124 | Identifying precursor phenotypes of pelvic organ prolapse by quantifying pelvic floor functional reserve: a novel approach to advancing prevention efforts | 000 | 1 | NIH | 8/4/2025 | $634,331 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32AI195016 | Elucidating the role of HIV-1 integrase in viral maturation | 000 | 1 | NIH | 7/23/2025 | $75,052 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EB038025 | Binding-Induced Enzyme Activation for Prodrug Therapy of HER2 Variants | 000 | 1 | NIH | 7/25/2025 | $331,920 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32AI195016 | Elucidating the role of HIV-1 integrase in viral maturation | 001 | 1 | NIH | 7/23/2025 | $0 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 3 | NIH | 2/13/2025 | $486,185 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K22NS123547 | The role of Infiltrating Macrophages in Seizure Generation Following CNS Infection | 003 | 5 | NIH | 7/30/2025 | $273,000 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA271740 | Investigating the regulation and mechanism of tension-sensors Stu2 & Ndc80c | 001 | 3 | NIH | 5/12/2025 | -$28,247 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA271740 | Investigating the regulation and mechanism of tension-sensors Stu2 & Ndc80c | 000 | 3 | NIH | 2/19/2025 | $43,133 |
|